AAPL338.40-2.67 (-0.78%) ▼|ABBV266.28+1.94 (+0.73%) ▲|ABT100.98-0.31 (-0.31%) ▼|ACN174.47-1.64 (-0.93%) ▼|ADBE231.01-4.46 (-1.89%) ▼|AMAT486.76+1.76 (+0.36%) ▲|AMD607.87-22.76 (-3.61%) ▼|AMGN418.13+3.52 (+0.85%) ▲|AMT168.00-1.03 (-0.61%) ▼|AMZN246.15-3.52 (-1.41%) ▼|AVGO349.57-3.24 (-0.92%) ▼|AXP306.33-2.56 (-0.83%) ▼|BA184.39-13.68 (-6.91%) ▼|BAC55.47-1.23 (-2.17%) ▼|BKNG163.87-0.08 (-0.05%) ▼|BLK1,071.25-15.06 (-1.39%) ▼|BMY63.88+1.02 (+1.62%) ▲|BNY148.44-1.71 (-1.14%) ▼|BRK-B503.09-2.39 (-0.47%) ▼|C131.31-2.97 (-2.21%) ▼|CAT819.95-1.63 (-0.20%) ▼|CL86.52+0.46 (+0.53%) ▲|CMCSA21.79-0.12 (-0.55%) ▼|COF196.46-3.74 (-1.87%) ▼|COP126.04-1.26 (-0.99%) ▼|COST922.92+0.16 (+0.02%) ▲|CRM227.27-6.75 (-2.88%) ▼|CSCO106.74+0.04 (+0.04%) ▲|CVS87.85-1.28 (-1.44%) ▼|CVX206.37+1.92 (+0.94%) ▲|DE689.59-0.87 (-0.13%) ▼|DHR227.33+2.84 (+1.27%) ▲|DIS105.59-0.56 (-0.53%) ▼|DUK113.41+0.06 (+0.05%) ▲|EMR159.39+1.16 (+0.73%) ▲|FDX289.65+3.80 (+1.33%) ▲|GD334.16-2.56 (-0.76%) ▼|GE318.24-8.85 (-2.71%) ▼|GEV949.77-7.86 (-0.82%) ▼|GILD152.21+1.28 (+0.85%) ▲|GM80.64-1.99 (-2.41%) ▼|GOOG339.16-1.92 (-0.56%) ▼|GOOGL342.75-1.17 (-0.34%) ▼|GS916.28-19.17 (-2.05%) ▼|HD289.89-3.31 (-1.13%) ▼|HON211.52-1.03 (-0.48%) ▼|IBM220.67-4.84 (-2.15%) ▼|INTC116.03-6.97 (-5.67%) ▼|INTU269.40-6.39 (-2.32%) ▼|ISRG414.79+9.61 (+2.37%) ▲|JNJ271.95+0.73 (+0.27%) ▲|JPM336.59-6.47 (-1.89%) ▼|KO87.18-0.63 (-0.72%) ▼|LIN472.04+2.15 (+0.46%) ▲|LLY1,184.78+1.32 (+0.11%) ▲|LMT518.10-1.46 (-0.28%) ▼|LOW187.66-1.62 (-0.86%) ▼|LRCX314.47-0.74 (-0.23%) ▼|MA568.26+0.61 (+0.11%) ▲|MCD233.60-2.90 (-1.23%) ▼|MDLZ60.18-0.07 (-0.12%) ▼|MDT89.50+0.86 (+0.97%) ▲|META715.62-36.04 (-4.79%) ▼|MMM169.48-0.07 (-0.04%) ▼|MO69.13+0.31 (+0.45%) ▲|MRK148.69-0.09 (-0.06%) ▼|MS193.64-2.67 (-1.36%) ▼|MSFT509.22-6.95 (-1.35%) ▼|MU1,053.98-28.30 (-2.61%) ▼|NEE75.49-0.59 (-0.78%) ▼|NFLX69.23-1.92 (-2.69%) ▼|NKE36.39+0.64 (+1.79%) ▲|NOW131.45-4.17 (-3.07%) ▼|NVDA228.86+3.79 (+1.68%) ▲|ORCL132.60-4.50 (-3.28%) ▼|PEP128.50-0.13 (-0.10%) ▼|PFE28.72+0.05 (+0.17%) ▲|PG149.03+2.80 (+1.91%) ▲|PLTR187.48-2.19 (-1.15%) ▼|PM193.76+3.28 (+1.72%) ▲|QCOM187.48-14.49 (-7.17%) ▼|RTX187.66-1.74 (-0.92%) ▼|SBUX95.27+0.41 (+0.43%) ▲|SCHW98.30-0.73 (-0.74%) ▼|SO82.35-0.53 (-0.64%) ▼|SPG204.53-0.29 (-0.14%) ▼|T24.90-0.48 (-1.89%) ▼|TMO678.60+3.60 (+0.53%) ▲|TMUS166.45+1.02 (+0.62%) ▲|TSLA357.45-14.66 (-3.94%) ▼|TXN278.31+0.24 (+0.09%) ▲|UBER68.16-1.46 (-2.10%) ▼|UNH377.83+1.24 (+0.33%) ▲|UNP274.10+0.31 (+0.11%) ▲|UPS94.25+0.29 (+0.31%) ▲|USB58.78-0.55 (-0.93%) ▼|V367.74+0.36 (+0.10%) ▲|VZ46.68-0.40 (-0.85%) ▼|WFC80.81-2.16 (-2.60%) ▼|WMT108.73+0.75 (+0.69%) ▲|XOM162.52+1.93 (+1.20%) ▲|AAPL338.40-2.67 (-0.78%) ▼|ABBV266.28+1.94 (+0.73%) ▲|ABT100.98-0.31 (-0.31%) ▼|ACN174.47-1.64 (-0.93%) ▼|ADBE231.01-4.46 (-1.89%) ▼|AMAT486.76+1.76 (+0.36%) ▲|AMD607.87-22.76 (-3.61%) ▼|AMGN418.13+3.52 (+0.85%) ▲|AMT168.00-1.03 (-0.61%) ▼|AMZN246.15-3.52 (-1.41%) ▼|AVGO349.57-3.24 (-0.92%) ▼|AXP306.33-2.56 (-0.83%) ▼|BA184.39-13.68 (-6.91%) ▼|BAC55.47-1.23 (-2.17%) ▼|BKNG163.87-0.08 (-0.05%) ▼|BLK1,071.25-15.06 (-1.39%) ▼|BMY63.88+1.02 (+1.62%) ▲|BNY148.44-1.71 (-1.14%) ▼|BRK-B503.09-2.39 (-0.47%) ▼|C131.31-2.97 (-2.21%) ▼|CAT819.95-1.63 (-0.20%) ▼|CL86.52+0.46 (+0.53%) ▲|CMCSA21.79-0.12 (-0.55%) ▼|COF196.46-3.74 (-1.87%) ▼|COP126.04-1.26 (-0.99%) ▼|COST922.92+0.16 (+0.02%) ▲|CRM227.27-6.75 (-2.88%) ▼|CSCO106.74+0.04 (+0.04%) ▲|CVS87.85-1.28 (-1.44%) ▼|CVX206.37+1.92 (+0.94%) ▲|DE689.59-0.87 (-0.13%) ▼|DHR227.33+2.84 (+1.27%) ▲|DIS105.59-0.56 (-0.53%) ▼|DUK113.41+0.06 (+0.05%) ▲|EMR159.39+1.16 (+0.73%) ▲|FDX289.65+3.80 (+1.33%) ▲|GD334.16-2.56 (-0.76%) ▼|GE318.24-8.85 (-2.71%) ▼|GEV949.77-7.86 (-0.82%) ▼|GILD152.21+1.28 (+0.85%) ▲|GM80.64-1.99 (-2.41%) ▼|GOOG339.16-1.92 (-0.56%) ▼|GOOGL342.75-1.17 (-0.34%) ▼|GS916.28-19.17 (-2.05%) ▼|HD289.89-3.31 (-1.13%) ▼|HON211.52-1.03 (-0.48%) ▼|IBM220.67-4.84 (-2.15%) ▼|INTC116.03-6.97 (-5.67%) ▼|INTU269.40-6.39 (-2.32%) ▼|ISRG414.79+9.61 (+2.37%) ▲|JNJ271.95+0.73 (+0.27%) ▲|JPM336.59-6.47 (-1.89%) ▼|KO87.18-0.63 (-0.72%) ▼|LIN472.04+2.15 (+0.46%) ▲|LLY1,184.78+1.32 (+0.11%) ▲|LMT518.10-1.46 (-0.28%) ▼|LOW187.66-1.62 (-0.86%) ▼|LRCX314.47-0.74 (-0.23%) ▼|MA568.26+0.61 (+0.11%) ▲|MCD233.60-2.90 (-1.23%) ▼|MDLZ60.18-0.07 (-0.12%) ▼|MDT89.50+0.86 (+0.97%) ▲|META715.62-36.04 (-4.79%) ▼|MMM169.48-0.07 (-0.04%) ▼|MO69.13+0.31 (+0.45%) ▲|MRK148.69-0.09 (-0.06%) ▼|MS193.64-2.67 (-1.36%) ▼|MSFT509.22-6.95 (-1.35%) ▼|MU1,053.98-28.30 (-2.61%) ▼|NEE75.49-0.59 (-0.78%) ▼|NFLX69.23-1.92 (-2.69%) ▼|NKE36.39+0.64 (+1.79%) ▲|NOW131.45-4.17 (-3.07%) ▼|NVDA228.86+3.79 (+1.68%) ▲|ORCL132.60-4.50 (-3.28%) ▼|PEP128.50-0.13 (-0.10%) ▼|PFE28.72+0.05 (+0.17%) ▲|PG149.03+2.80 (+1.91%) ▲|PLTR187.48-2.19 (-1.15%) ▼|PM193.76+3.28 (+1.72%) ▲|QCOM187.48-14.49 (-7.17%) ▼|RTX187.66-1.74 (-0.92%) ▼|SBUX95.27+0.41 (+0.43%) ▲|SCHW98.30-0.73 (-0.74%) ▼|SO82.35-0.53 (-0.64%) ▼|SPG204.53-0.29 (-0.14%) ▼|T24.90-0.48 (-1.89%) ▼|TMO678.60+3.60 (+0.53%) ▲|TMUS166.45+1.02 (+0.62%) ▲|TSLA357.45-14.66 (-3.94%) ▼|TXN278.31+0.24 (+0.09%) ▲|UBER68.16-1.46 (-2.10%) ▼|UNH377.83+1.24 (+0.33%) ▲|UNP274.10+0.31 (+0.11%) ▲|UPS94.25+0.29 (+0.31%) ▲|USB58.78-0.55 (-0.93%) ▼|V367.74+0.36 (+0.10%) ▲|VZ46.68-0.40 (-0.85%) ▼|WFC80.81-2.16 (-2.60%) ▼|WMT108.73+0.75 (+0.69%) ▲|XOM162.52+1.93 (+1.20%) ▲|
17.1 C
New York
Tuesday, September 29, 2026

Tag: company

newssourceFORcompanyinformationcontent1releasesmarket

Sensing Meets Connectivity: Calterah Launches Ultra-Powerful mmWave Radar Chips for High-Performance ADAS and Leading-Edge UWB Radar Solutions

SHANGHAI, June 8, 2026 /PRNewswire/ -- On June 5, 2026, Calterah, a global leader in mmWave radar chips, unveiled its latest high-performance radar SoCs for...

Sensing Meets Connectivity: Calterah Launches Ultra-Powerful mmWave Radar Chips for High-Performance ADAS and Leading-Edge UWB Radar Solutions

SHANGHAI, June 8, 2026 /PRNewswire/ -- On June 5, 2026, Calterah, a global leader in mmWave radar chips, unveiled its latest high-performance radar SoCs for...

TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia

BANDUNG, Indonesia, June 8, 2026 /PRNewswire/ -- TotalEnergies ENEOS successfully completed Phase 2 of a rooftop solar photovoltaic (PV) project with PT. Perusahaan Industri Ceres...

Solidion Technology Announces $35 Million Private Placement of Common Stock Priced Above Market Under Nasdaq Rules

Proceeds fully fund the company through 2028 and will be used to accelerate commercialization of Solidion’s patented Extreme-Climate Battery Technology targeting the Lunar economy and
space applications

Vi Appoints Spencer Honeyman as President, Global Growth

NEW YORK, June 7, 2026 /PRNewswire/ -- Vi today announced the promotion of Spencer Honeyman to President, Global Growth. ...

Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your...

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 7, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 7, 2026 /CNW/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

SAN DIEGO, June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for...

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37...

HONG KONG, June 7, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the presentation of three key studies at the American Diabetes...

BLACKYAK Hosts “Himalayan Climate Charter 2026: Namche Summit” to Advance Global Climate Action

- Highlights the climate crisis facing the Himalayas and underscores the need for international solidarity and collective action- Held in Namche Bazaar, Nepal, the...

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas 
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers